Flowable Vitreous Carbon Foam Bone Graft Substitute

THE TECHNOLOGY

Particulate materials derived from controlled breakage of vitreous carbon foam constructs have been developed as a platform technology for multiple medical procedures performed to address diverse tissue deficits and/or pathologies. The results of these studies have revealed that particulate vitreous carbon foam-derived particles are biocompatible, permissive of cell attachment and differentiation, bind regenerative-important growth factors in an active elutable form, and provide a 3-dimensional substrate that encourages rapid neo-vascularization and bone formation. These materials can be formulated into flowable gels, putties and granules, enabling them to be used in a multitude of clinical applications.

BENEFITS

  • Improved binding, retention, and delivery of drugs and cytokines
  • Increased surgical options without the need to harvest bone for grafting procedures
  • Effective bone formation with significantly reduced biological response modifier dosage
  • Flowable configuration increases surgical handling options
  • Reduced out-of-pocket expense as compared to other osteoinductive bone graft substitute products
  • Potential decrease in off-target side effects of therapeutic agents

APPLICATION

  • Spinal fusion
  • General orthopedics
  • Vertebroplasty
  • Wound care
  • Oral and maxillofacial surgery

OPPORTUNITY

  • Available for license/purchase and patent-pending
  • Potential for ongoing collaboration with inventors Stephen Miller, Nora Strong, and Joel White
Flowable

QUICK INFO
Inventor(s):
  • Stephen Miller
  • Nora Strong
  • Joel White

Reference Number:
15V125

Download a Printable PDF

CONTACT
Becky Hundley
Contracts & Intellectual Property Manager
becky.hundley@wichita.edu
316.978.5199